SFM
VERA icon

Sphera Funds Management’s Vera Therapeutics VERA Stock Holding History

Sphera Funds Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-105,000
Closed -$1.44M – 106
2023
Q3 		$1.44M Hold
105,000
– – 0.26% 69
2023
Q2 		$1.69M Buy
+105,000
New +$948K 0.26% 75

Other funds holding VERA

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's VERA Position: Q4 2023 in Review

Sphera Funds Management sold out of Vera Therapeutics (VERA) in Q4 2023, closing a stake of 105,000 shares — an estimated $1.44M sold.

Sphera Funds Management first reported a position in VERA in Q2 2023 and held it in 2 quarters. The position peaked at $1.69M in Q2 2023. 95 funds tracked by Wall St. Rank hold VERA as of Q4 2023.

  • Sphera Funds Management reported no remaining Vera Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Sphera Funds Management sold 105,000 Vera Therapeutics shares in Q4 2023, an estimated $1.44M.
  • Sphera Funds Management first reported a position in Vera Therapeutics in Q2 2023 and held it in 2 quarters.
  • Sphera Funds Management's Vera Therapeutics position peaked at $1.69M in Q2 2023.
  • 95 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2023.

Based on Sphera Funds Management's 13F filing for Q4 2023, filed 14 Feb 2024.